Key result
Ppp1r12c knockout causes severe diastolic dysfunction in mice, cutting mitral E velocity by ~37%.
Why the study?
Diastolic heart failure has limited therapeutic options, and the specific contributions of myosin light chain phosphatase subunits to cardiac muscle relaxation and DHF pathology remain unclear.
Does genetic ablation of Ppp1r12c cause hypertension and diastolic dysfunction in mice?
Does genetic ablation of Ppp1r12c cause hypertension and diastolic dysfunction in mice?
Genetic deficiency of the myosin phosphatase regulatory subunit Ppp1r12c in mice leads to early-onset hypertension, progressive diastolic dysfunction, sarcomere remodeling, and impaired mitochondrial energetics, identifying a potential molecular mechanism in diastolic heart failure.
Ppp1r12c knockout models diastolic dysfunction in mice; leaves open its role in human HFpEF and need for translational validation.
Background and Aims Diastolic heart failure (DHF) is a growing clinical challenge with limited therapeutic options. Myosin light chain phosphatase (MLCP), a key regulator of cardiac relaxation, plays a central role in diastolic function. However, the specific contributions of MLCP subunits to cardiac muscle relaxation and DHF pathology remain unclear. This study aims to investigate these mechanisms to address critical gaps in understanding and advance the potential for targeted interventions. Methods This study determined the role of the regulatory protein phosphatase 1 subunit 12C, a MLCP protein subunit encoded by the Ppp1r12c gene in mice (human ortholog: PPP1R12C), in cardiac physiology and pathology using a Ppp1r12c knockout (12C-KO) mouse model. Through a combination of physiological assessments, echocardiography, electron microscopy, and multi-omics analyses, we delineate the effects of Ppp1r12c gene ablation upon cardiac structure and function. Results 12C-KO mice develop hypertension starting at 1-2 months of age, resulting in severe diastolic dysfunction versus wild type controls at six months of age including echo Doppler parameters showing: decreased E velocity (372±126 vs. 590±156, P = 0.03, n = 5 per group), decreased E′ velocity (9.37±2.30 vs. 15.58±3.53, P = 0.01), increased isovolumetric relaxation time (21.40±2.76 vs. 15.05±2.61, P = 0.02), decreased mitral valve acceleration time (263±120 vs. 482±124, P = 0.02), and decreased mitral valve deceleration time (11.39±2.92 vs. 18.80±4.30, P = 0.03). Ultrastructural analyses show sarcomere elongation and Z-line irregularities, consistent with sarcomere remodeling. Transcriptomic and proteomic profiling indicates disrupted gene and protein expression patterns commonly seen in cardiomyopathy and decreased oxidative phosphorylation without compensatory upregulation of other MLCP subunits. Conclusions The protein phosphatase 1 regulatory subunit 12C (Ppp1r12c) plays a significant role in regulating blood pressure and cardiac relaxation. Genetic ablation of Ppp1r12c in mice leads to early onset of hypertension and progressive diastolic dysfunction, which is related to sarcomere remodeling and mitochondrial dysfunction. The 12C-KO mouse is associated with sarcomeric remodeling and impaired energetic homeostasis.
No takes yet. Share an insight, caveat, or question.
Mccauley et al. (2026) studied Diastolic heart failure (n=10). Ppp1r12c gene knockout (12C-KO) vs. Wild type control mice was evaluated on Diastolic function by echo Doppler parameters (E velocity, E' velocity, isovolumetric relaxation time, mitral valve acceleration and deceleration times) (p=0.03). Ppp1r12c gene knockout in mice caused severe diastolic dysfunction vs wild type at 6 months, including reduced E velocity (372±126 vs 590±156, P=0.03) and E' velocity (9.37±2.30 vs 15.58±3.53, P=0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: